As of 2025-05-30, the Intrinsic Value of Suzhou MedicalSystem Technology Co Ltd (603990.SS) is (499.74) CNY. This 603990.SS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 15.09 CNY, the upside of Suzhou MedicalSystem Technology Co Ltd is -3,411.70%.
The range of the Intrinsic Value is (1,785.62) - (290.68) CNY
Based on its market price of 15.09 CNY and our intrinsic valuation, Suzhou MedicalSystem Technology Co Ltd (603990.SS) is overvalued by 3,411.70%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (1,785.62) - (290.68) | (499.74) | -3411.7% |
| DCF (Growth 10y) | (2,215.63) - (15,583.08) | (4,072.68) | -27089.3% |
| DCF (EBITDA 5y) | (78.87) - (107.74) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (566.81) - (758.28) | (1,234.50) | -123450.0% |
| Fair Value | -4.34 - -4.34 | -4.34 | -128.75% |
| P/E | (11.51) - (17.55) | (14.53) | -196.3% |
| EV/EBITDA | (6.41) - (8.71) | (6.63) | -144.0% |
| EPV | (9.77) - (15.34) | (12.55) | -183.2% |
| DDM - Stable | (6.56) - (43.19) | (24.88) | -264.8% |
| DDM - Multi | (119.22) - (661.42) | (207.52) | -1475.2% |
| Market Cap (mil) | 4,621.77 |
| Beta | 1.30 |
| Outstanding shares (mil) | 306.28 |
| Enterprise Value (mil) | 4,943.64 |
| Market risk premium | 6.13% |
| Cost of Equity | 9.53% |
| Cost of Debt | 5.00% |
| WACC | 8.11% |